Suchergebnisse - (Subject:"2494G1JF75")

PubPharm (1.007)

71

Plasma metabolic changes in Chinese HIV-infected patients receiving lopinavir/ritonavir based treatment : Implications for HIV precision therapy

enthalten in: Cytokine | 2018

von Li, X. | Wu, T. | Jiang, Y. | +7

72

Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women

enthalten in: British journal of clinical pharmacology | 2018

von Ribeiro, R. | Moreira, F. | Moisés, E. | +4

73

Lopinavir, an HIV-1 peptidase inhibitor, induces alteration on the lipid metabolism of Leishmania amazonensis promastigotes

enthalten in: Parasitology | 2018

von Rebello, K. | Andrade-Neto, V. | Zuma, A. | +8

74

Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells

enthalten in: Molecules (Basel, Switzerland) | 2018

von Basile, M. | Mazzon, E. | Krajnovic, T. | +7

75

Preventing loss of mechanosensation by the nuclear membranes of alveolar cells reduces lung injury in mice during mechanical ventilation

enthalten in: Science translational medicine | 2018

von López-Alonso, I. | Blázquez-Prieto, J. | Amado-Rodríguez, L. | +7

76

Biomarkers of Aging in HIV-Infected Children on Suppressive Antiretroviral Therapy

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2018

von Shiau, S. | Strehlau, R. | Shen, J. | +11

77

Primary evidence of the mechanisms of action of HIV aspartyl peptidase inhibitors on Trypanosoma cruzi trypomastigote forms

enthalten in: International journal of antimicrobial agents | 2018

von Sangenito, L. | Menna-Barreto, R. | Oliveira, A. | +3

78

HIV aspartyl protease inhibitors modify the percentage of activated leukocytes, as well as serum levels of IL-17A and NO during experimental leishmaniasis

enthalten in: International immunopharmacology | 2018

von Alvarenga, D. | Silva, A. | Fiuza, J. | +6

79

Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs

enthalten in: The Journal of antimicrobial chemotherapy | 2018

von Puertas, M. | Gómez-Mora, E. | Santos, J. | +11

80

Identification of Highly Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors against Lopinavir and Darunavir Resistant Viruses from Allophenylnorstatine-Based Peptidomimetics with P2 Tetrahydrofuranylglycine

enthalten in: Journal of medicinal chemistry | 2018

von Hidaka, K. | Kimura, T. | Sankaranarayanan, R. | +9